Trial Profile
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 May 2014
Price :
$35
*
At a glance
- Drugs Bamosiran (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Sylentis
- 07 May 2014 New trial record